Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

The board of directors of AbbVie Inc. revealed that it intends to reconsider its decision to recommend the companys investors to support the takeover of Shire Plc amid changing tax rules in the U.S. The acquisition of Shire is estimated to $55 billion.

AbbVie said in an official statement, cited by Bloomberg, that there is a board meeting scheduled for October 20th to consider “the impact of the U.S. Department of Treasury’s proposed unilateral changes to the tax regulations announced on Sept. 22, including the impact to the fundamental financial benefits of the transaction”. As reported by the Financial Times, the company also noted: “AbbVie’s board will consider, among other things, the impact of the US Department of Treasury’s proposed unilateral changes to the tax regulations announced on September 22, 2014, including the impact to the fundamental financial benefits of the transaction.”

The Treasury Department rules were announced in September and were considered to have aimed to discourage local companies to move their headquarters overseas for tax purposes. After the new financial benefits were announced by the Treasury, analysts expressed their concerns that these deals, known as inversions, have become more difficult and less attractive to companies themselves.

The proposed takeover was announced on July 18th. Now, the company seems to be withdrawing from the deal. A spokeswoman of AbbVie, Ms. Jennifer Smoter, refused to make any further comments apart from the statement the company already made. An official representative of the Treasury Department also declined to comment on any specific transactions.

As reported by Bloomberg, AbbVie also said: “AbbVie’s offer will lapse if the company’s stockholders do not adopt the agreement.”

AbbVie Inc. was 0.95% up to close at $54.13 per share yesterday, marking a one-year increase of 16.84%. The company is valued at $85.44 billion. According to CNN Money, the 9 analysts offering 12-month price forecasts for AbbVie Inc. have a median target of $67.00, with a high estimate of $85.00 and a low estimate of $54.00. The median estimate represents a +23.78% increase from the last price of $54.13.

TradingPedia.com is a financial media specialized in providing daily news and education covering Forex, equities and commodities. Our academies for traders cover Forex, Price Action and Social Trading.

Related News

  • Copper Faces Key Technical Standoff Below 200-SMACopper Faces Key Technical Standoff Below 200-SMA Key Moments Copper is trading below the 200-period simple moving average on the 5-hour chart, with price pinned in the $6.41–$6.57 zone amid strong bearish momentum. The Money Flow Index sits at 13.4, signaling deeply oversold […]
  • Spot Gold off record high, heads for 5th weekly gainSpot Gold off record high, heads for 5th weekly gain Spot Gold pulled back from yesterday's record high, but was set to register its fifth straight week of gains, as market players reassessed risk outlook following the US' sweeping tariff measures.This week, the Trump administration […]
  • Forex Market: AUD/USD surges as RBA hikes at faster pace than expected, flags further tighteningForex Market: AUD/USD surges as RBA hikes at faster pace than expected, flags further tightening AUD/USD traded within an almost 100-pip range on Tuesday, after the Reserve Bank of Australia (RBA) surprised markets, delivering the largest interest rate hike in 22 years and signaled more hikes were on the horizon.The RBA raised […]
  • Gold trading outlook: futures climb on Ukraine worriesGold trading outlook: futures climb on Ukraine worries Gold futures were higher during early trade in Europe today, as growing worries over a Russian invasion in Ukraine pushed haven demand up. Several key economic readings are due today, as investors seek more data to reinforce an […]
  • Forex Market: USD/CAD daily trading forecastForex Market: USD/CAD daily trading forecast Friday’s trade saw USD/CAD within the range of 1.1946-1.2046. The daily high has also been the highest level since April 29th 2009. The pair closed at 1.1985, gaining 0.21% on a daily basis.At 8:32 GMT today USD/CAD was down 0.10% for the […]
  • ADM opens new $30 million production facility in SpainADM opens new $30 million production facility in Spain In an attempt to meet rising global demand for probiotics, postbiotics and other health-supporting products, ADM (NYSE: ADM), a provider of science-backed nutrition solutions, announced the opening of a new production facility in Valencia, […]